The histopathological and immunohistochemical characteristics of pigmentary and cystic glaucoma in the Golden Retriever

Veterinary Ophthalmology

Volumn 12, Issue 6, 2009, Pages 361-368

  Esson, Douglas ^a   Armour, Micki ^a   Mundy, Patricia ^b   Schobert, Charles S ^b   Dubielzig, Richard R ^b  

^a Eye Care For Animals   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cystic; Glaucoma; Golden Retriever; Histopathological; Pigmentary

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; GENETIC PREDISPOSITION; GENETICS; GLAUCOMA; IMMUNOHISTOCHEMISTRY; OPEN ANGLE GLAUCOMA; PATHOLOGY;

ANIMALS; DOG DISEASES; DOGS; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; IMMUNOHISTOCHEMISTRY;

ANIMALIA;

EID: 70350492758     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2009.00732.x     Document Type: Article

References (30)

1. Sapienza JS, Simo FJ, Prades-Sapienza A. Golden Retriever uveitis: 75 cases (1994-1999). Veterinary Ophthalmology 2000 3 : 241 246.
2. Deehr AJ, Dubielzig RR. A histopathological study of iridociliary cysts and glaucoma in Golden Retrievers. Veterinary Ophthalmology 1998 1 : 153 158.
3. Mo JS, Wang W, Kaplan HJ. Impact of inflammation on ocular immune privilege. Chemical Immunology and Allergy 2007 92 : 155 165.
4. Streilein JW, Ohta K, Mo JS et al. Ocular immune privilege and the impact of intraocular inflammation. DNA and Cell Biology 2002 21 : 453 459.
5. Bellhorn RW. An overview of the blood-ocular barriers. Progress in Veterinary and Comparative Ophthalmology 1990 1 : 12.
6. Massa KL, Gilger BC, Miller TL et al. Causes of uveitis in dogs: 102 cases (1989-2000). Veterinary Ophthalmology 2002 5 : 93 98.
7. Li Z, Liu B, Maminishkis A et al. Gene expression profiling in autoimmune noninfectious uveitis disease. Journal of Immunology 2008 181 : 5147 5157.
8. Deeg CA, Raith AJ, Amann B et al. CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clinical Developmental Immunology 2007 2007 : 39245.
9. Corcoran KA, Koch SA. Uveal cysts in dogs: 28 cases (1989-1991). Journal of the American Veterinary Medical Association 1993 203 : 545 546.
10. Spiess BM, Bolliger JO, Guscetti F et al. Multiple ciliary body cysts and secondary glaucoma in the Great Dane: a report of nine cases. Veterinary Ophthalmology 1998 1 : 41 45.
11. McKay EO, Kallberg ME, Barrie KP et al. Myocilin protein levels in the aqueous humor of the glaucomas in selected canine breeds. Veterinary Ophthalmology 2008 11 : 234 241.
12. Petersen-Jones SM, Forcier J, Mentzer AL. Ocular melanosis in the Cairn Terrier: clinical description and investigation of mode of inheritance. Veterinary Ophthalmology 2007 10 (Suppl. 1 63 69.
13. Petersen-Jones SM, Mentzer AL, Dubielzig RR et al. Ocular melanosis in the Cairn Terrier: histopathological description of the condition, and immunohistological and ultrastructural characterization of the characteristic pigment-laden cells. Veterinary Ophthalmology 2008 11 : 260 268.
14. Petersen-Jones SM, Mould JR. Chronic glaucoma in cairn terriers. Veterinary Record 1991 128 : 619.
15. Gelatt KN, MacKay EO. Secondary glaucomas in the dog in North America. Veterinary Ophthalmology 2004 7 : 245 259.
16. Gelatt KN, MacKay EO. Prevalence of the breed-related glaucomas in pure-bred dogs in North America. Veterinary Ophthalmology 2004 7 : 97 111.
17. Martin CL, Wyman M. Primary glaucoma in the dog. The Veterinary Clinics of North America 1978 8 : 257 286.
18. Martinelli AM. Glaucoma. Classifications, treatment options, patient care. AORN Journal 1991 54 : 743 748. 50-3, 55-7.
19. Reilly CM, Morris R, Dubielzig RR. Canine goniodysgenesis-related glaucoma: a morphologic review of 100 cases looking at inflammation and pigment dispersion. Veterinary Ophthalmology 2005 8 : 253 258.
20. Bennett DC. Mechanisms of differentiation in melanoma cells and melanocytes. Environmental Health Perspectives 1989 80 : 49 59.
21. Pawelek JM, Lerner AB. 5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature 1978 276 : 626 628.
22. Smit NPMPS, Riley PA. Mechanisms of control of the cytotoxicity of orthoquinone intermediates of melanogenesis. In : Role of Catechol Quinone Species in Cellular Toxicity ed. Creveling CR) FP Graham Publishing, Johnaon City, TN, 2000 191 245.
23. Murisier F, Beermann F. Genetics of pigment cells: lessons from the tyrosinase gene family. Histology and Histopathology 2006 21 : 567 578.
24. Beermann F, Hunziker A, Foletti A. Transgenic mouse models for tumors of melanocytes and retinal pigment epithelium. Pigment Cell Research 1999 12 : 71 80. (Pubitemid 129686000)
25. Beermann F, Schmid E, Ganss R et al. Molecular characterization of the mouse tyrosinase gene: pigment cell-specific expression in transgenic mice. Pigment Cell Research 1992 5 (5 Pt 2 295 299.
26. Beermann F, Schmid E, Schutz G. Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1992 89 : 2809 2813.
27. Bora NS, Woon MD, Tandhasetti MT et al. Induction of experimental autoimmune anterior uveitis by a self-antigen: melanin complex without adjuvant. Investigative Ophthalmology and Visual Science 1997 38 : 2171 2175.
28. Mo JS, Anderson MG, Gregory M et al. By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma. Journal of Experimental Medicine 2003 197 : 1335 1344.
29. Yamaki K, Gocho K, Hayakawa K et al. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. Journal of Immunology 2000 165 : 7323 7329.
30. Anderson MG, Nair KS, Amonoo LA et al. GpnmbR150X allele must be present in bone marrow derived cells to mediate DBA/2J glaucoma. BMC Genetics 2008 9 : 30.